GODOLPHIN (Pertinent news & discussion prior to the IPO), page-59

Hello Everyone
Today I received in the post my prospectus / Notice of Extraordinary General Meeting.

My 2 minute snapshot is:
The General Meeting will be held on 04 November 2019
If the spinout is approved in the general meeting we will list on the ASX as Godolphin on the 13 December 2019
The In Specie distribution will be 30 million shares if approved in the GM
The opportunity to buy extra shares as a priority allocation will cease on 18 November2019

Reasons for the spinout are as I have previously indicated, that:
- Shareholders will have value returned to them through the spinout of NSW
- Godolphin can develop the assets more efficiently having a dedicated team with the sole purpose of creating value for shareholders.
- Legacy ARL directors that will have shares at the IPO of Godolphin will be Ian Buchhorn and Katrina Law.
- Overseas ARL shareholders will need to get creative to receive their in specie free shares or be paid out in cash. You are forewarned.
- There will be a LOYALTY OPTION allocation to raise funding for the development of NSW, Same as ARL, 3 months post listing.
- Godolphin will list with Ian Buchhorn owning 10.9% of the company

We are on the way to Godolphin listing on 13 December 2019.
I AM VERY HAPPY and will vote in favor of the spinout.
This will happen IMO
RED